SCHEMBL1830401

SCHEMBL1830401

CCCCCCCCCCCCC1CC(=O)C1.CCCCCCCCCCCCCCC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PRKCA P17252 2/20 0.40
ALOX5 P09917 1/20 0.40
CES2 O00748 3/20 0.39
CES1 P23141 3/20 0.39
TLR4 O00206 1/20 0.38
PPARG P37231 4/20 0.38
PPARD Q03181 4/20 0.38
PPARA Q07869 4/20 0.38
TSHR P16473 3/20 0.38
GPR84 Q9NQS5 3/20 0.38
HDAC11 Q96DB2 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
TLR2 O60603 1/20 0.38
MEN1 O00255 1/20 0.38
ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5274773 0.88 CYP1A2 (0.45) CYP1A2ALDH1A1L3MBTL1PRKCAALOX5
SCHEMBL6707183 0.86 CYP1A2 (0.53) CYP1A2ALDH1A1L3MBTL1ALOX5PPARG
SCHEMBL19976638 0.86 CYP1A2 (0.53) CYP1A2ALDH1A1L3MBTL1ALOX5PPARG
SCHEMBL2690939 0.86 CYP1A2 (0.53) CYP1A2ALDH1A1L3MBTL1ALOX5PPARG
SCHEMBL2691445 0.84 CYP1A2 (0.55) CYP1A2ALDH1A1L3MBTL1PPARGMEN1
SCHEMBL7995818 0.83 CYP1A2 (0.41) CYP1A2TLR4
SCHEMBL11832316 0.82 CYP1A2 (0.50) CYP1A2ALDH1A1L3MBTL1PRKCAALOX5
SCHEMBL299169 0.81 SCD (0.42) ALDH1A1L3MBTL1PRKCAALOX5CES2
SCHEMBL5210228 0.80 CYP1A2 (0.52) CYP1A2ALDH1A1L3MBTL1PRKCAALOX5
SCHEMBL10248877 0.78 ALDH1A1 (0.39) ALDH1A1TLR4MEN1PTPN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861364-B1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION C P PHARMACEUTICALS INTERNAT C V (US) 2011-05-11 EP claimed
EP-0876323-B1 PROCESS FOR PREPARING CYCLOPENTENONES ALBEMARLE CORP (US) 2000-06-28 EP claimed
EP-0352944-B1 Derivatives of N-phenylpyrazoles RHONE POULENC AGRICULTURE (GB) 1995-03-01 EP claimed
EP-0390370-B1 AQUEOUS COATING COMPOSITIONS ZENECA LIMITED (GB) 1993-06-09 EP claimed
EP-3110784-A1 SYNTHESIS OF DIKETONE COMPOUNDS FROM CARBOHYDRATES Rhodia Operations (FR) 2017-01-04 EP disclosed
WO-2015127662-A1 SYNTHESIS OF DIKETONE COMPOUNDS FROM CARBOHYDRATES RHODIA OPERATIONS (FR) 2015-09-03 WO disclosed
EP-1861364-B1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION C P PHARMACEUTICALS INTERNAT C V (US) 2011-05-11 EP disclosed
EP-1861364-A1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION Pfizer Science and Technology Ireland Limited (IE) 2007-12-05 EP disclosed
WO-2006097909-A1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED (IE) 2006-09-21 WO disclosed
EP-1480943-A2 SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS Teva Pharmaceutical Industries Limited (IL) 2004-12-01 EP disclosed
WO-2004046105-A3 SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS TEVA PHARMA (IL) 2004-10-07 WO disclosed
WO-2004046105-A2 SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-06-03 WO disclosed
EP-0876323-B1 PROCESS FOR PREPARING CYCLOPENTENONES ALBEMARLE CORP (US) 2000-06-28 EP disclosed
EP-0876323-A1 PROCESS FOR PREPARING CYCLOPENTENONES ALBEMARLE CORPORATION (US) 1998-11-11 EP disclosed
WO-1997019905-A1 PROCESS FOR PREPARING CYCLOPENTENONES ALBEMARLE CORPORATION (US) 1997-06-05 WO disclosed